Literature DB >> 33845908

Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation.

Bianca Nowlan1,2,3, Kathryn Futrega3,4,5, Elizabeth Deborah Williams1,2,3, Michael Robert Doran6,7,8,9,10,11,12.   

Abstract

BACKGROUND: Direct bone marrow injection of cells into murine marrow cavities is used in a range of cell characterization assays and to develop disease models. While human bone marrow-derived stromal cells (hBMSC, also known as mesenchymal stem cells (MSC)) are frequently described in therapeutic applications, or disease modeling, their behavior following direct injection into murine bone marrow is poorly characterized. Herein, we characterized hBMSC engraftment and persistence within the bone marrow of NOD-scid interleukin (IL)-2γ-/- (NSG) mice with or without prior 2 Gy total-body γ-irradiation of recipient mice.
METHODS: One day after conditioning NSG mice with sublethal irradiation, 5 × 105 luciferase (Luc) and green fluorescent protein (GFP)-expressing hBMSC (hBMSC-Luc/GFP) were injected into the right femurs of animals. hBMSC-Luc/GFP were tracked in live animals using IVIS imaging, and histology was used to further characterize hBMSC location and behavior in tissues.
RESULTS: hBMSC-Luc/GFP number within injected marrow cavities declined rapidly over 4 weeks, but prior irradiation of animals delayed this decline. At 4 weeks, hBMSC-Luc/GFP colonized injected marrow cavities and distal marrow cavities at rates of 2.5 ± 2.2% and 1.7 ± 1.9% of total marrow nucleated cells, respectively in both irradiated and non-irradiated mice. In distal marrow cavities,  hBMSC were not uniformly distributed and appeared to be co-localized in clusters, with the majority found in the endosteal region.
CONCLUSIONS: While significant numbers of hBMSC-Luc/GFP could be deposited into the mouse bone marrow via direct bone marrow injection, IVIS imaging indicated that the number of hBMSC-Luc/GFP in that bone marrow cavity declined with time. Irradiation of mice prior to transplant only delayed the rate of hBMSC-Luc/GFP population decline in injected femurs. Clusters of hBMSC-Luc/GFP were observed in the histology of distal marrow cavities, suggesting that some transplanted cells actively homed to distal marrow cavities. Individual cell clusters may have arisen from discrete clones that homed to the marrow, and then underwent modest proliferation. The transient high-density population of hBMSC within the injected femur, or the longer-term low-density population of hBMSC in distal marrow cavities, offers useful models for studying disease or regenerative processes. Experimental designs should consider how relative hBMSC distribution and local hBMSC densities evolve over time.

Entities:  

Keywords:  Bone marrow; Cell competition; Human bone marrow-derived stromal cells; Intrafemoral injection; Sub-lethal irradiation; Xenograft

Year:  2021        PMID: 33845908     DOI: 10.1186/s13287-021-02297-7

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  40 in total

1.  Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.

Authors:  Frédéric Mazurier; Monica Doedens; Olga I Gan; John E Dick
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

2.  Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration.

Authors:  Ronald van Os; Albertina Ausema; Bert Dontje; Manon van Riezen; Gooitzen van Dam; Gerald de Haan
Journal:  Exp Hematol       Date:  2010-07-17       Impact factor: 3.084

3.  Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.

Authors:  Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

4.  Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.

Authors:  Eva Corey; Janna E Quinn; Franck Bladou; Lisha G Brown; Martine P Roudier; Julie M Brown; Kent R Buhler; Robert L Vessella
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

5.  Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells.

Authors:  Joby L McKenzie; Olga I Gan; Monica Doedens; John E Dick
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

6.  Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.

Authors:  S Carrancio; C Romo; T Ramos; N Lopez-Holgado; S Muntion; H J Prins; A C Martens; J G Briñón; J F San Miguel; M C Del Cañizo; F Sanchez-Guijo
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 7.  Regulation of hematopoietic stem cells by bone marrow stromal cells.

Authors:  Bryan A Anthony; Daniel C Link
Journal:  Trends Immunol       Date:  2013-11-05       Impact factor: 16.687

8.  Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition.

Authors:  N Patrick McCabe; Maria Madajka; Amit Vasanji; Tatiana V Byzova
Journal:  Clin Exp Metastasis       Date:  2008-05-28       Impact factor: 5.150

Review 9.  The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.

Authors:  Y Shiozawa; A M Havens; K J Pienta; R S Taichman
Journal:  Leukemia       Date:  2008-02-28       Impact factor: 11.528

10.  Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice.

Authors:  Kathryn Futrega; William B Lott; Michael R Doran
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

View more
  1 in total

1.  Direct bone marrow injection of human bone marrow-derived stromal cells into mouse femurs results in greater prostate cancer PC-3 cell proliferation, but not specifically proliferation within the injected femurs.

Authors:  Bianca Nowlan; Elizabeth D Williams; Michael Robert Doran
Journal:  BMC Cancer       Date:  2022-05-17       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.